Reference Traber MG, Elsner A, Brigelius-Floh R
Tirzepatide has established proof-of-concept for the GIP/GLP-1 receptor agonist mechanism of action, but the pipeline extends further
The cant even hold you
On the 29th, Seoul National University Hospital announced that a joint research teamcomprising Professor Seon-ha Baek's team from Neurosurgery, Professor Jong-ryeol Roh's team from Otolaryngology at Cha Bundang Medical Center, and researcher Jae-wang Lee from Log-Syncpublished a review paper analyzing the effects of long-term administration of GLP-1 class obesity drugs on systemic metabolism
Increased Libido: This is another well-documented effect mediated by the melanocortin system
Similar to BMIS, microbiota composition and dietary variables alone performed poorly, explaining on average 2% and 1% of TMAO variance, respectively, in T2D and IHD individuals (Fig